MO

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 1998, for Philip Morris Companies Inc. (Note: The request metadata listed "Altria Group," but the filing text explicitly identifies the registrant as Philip Morris Companies Inc.). The Company operates primarily in Tobacco, Food, Beer, and Financial Services segments. The financial statements are unaudited.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Operating revenues increased 2.0% year-over-year, driven by domestic tobacco, international tobacco, and North American food operations. Underlying revenues (excluding divestitures) increased 3.1%.
• Profit Decline: Operating income decreased 14.0% and Net Earnings decreased 13.6%. This decline was primarily due to significant charges related to tobacco litigation settlements and voluntary early retirement programs.
• Unusual Items:
  • Settlement Charges: $1,005 million in pre-tax charges were recorded for tobacco litigation settlements (Minnesota, Mississippi, Texas, and "Most Favored Nation" amendments).
  • Restructuring: $327 million in pre-tax charges for voluntary early retirement and separation programs.
• Currency Impact: A strengthening U.S. dollar reduced operating revenues by $1.7 billion and operating income by $224 million compared to the prior year.
• Segment Performance:
  • Tobacco: Domestic operating income fell 53.6% due to litigation charges; International operating income rose 11.1%.
  • Food: North American operating income rose 8.2%; International operating income fell 9.5% due to currency and divestitures.
  • Beer: Operating income remained relatively flat.

Guidance, Outlook, and Risks

• Outlook: Management anticipates the continued strength of the U.S. dollar will have a significant adverse impact on revenues and income for the remainder of 1998 and 1999. Economic instability in Asia is expected to slow business in that region.
• Year 2000 (Y2K): The Company estimates total Y2K remediation costs between $400 million and $500 million. While internal systems are being addressed, risks remain regarding the readiness of key business partners and utilities, particularly in international markets.
• Legal and Regulatory Risks:
  • Litigation: Approximately 400 individual smoking/health cases and 140 health care cost recovery cases are pending. The Company cannot predict outcomes or estimate potential losses.
  • Legislation: Federal tobacco legislation (e.g., the "Commerce Bill") is under consideration, which could impose significant payments and regulatory controls. State-level ingredient disclosure laws are also a risk.
  • Settlements: Recent amendments to Mississippi and Texas settlements require additional payments totaling $2.825 billion over five years.
• Dividends: The quarterly dividend remains $0.40 per share.

Investor Verification Checklist

• Litigation Exposure: Verify the status of the "Engle" class action trial in Florida and the Washington state health care cost recovery trial scheduled for September 1998.
• Settlement Obligations: Confirm the cash flow impact of the amended Mississippi and Texas settlement agreements ($2.825 billion total over 5 years).
• Underlying Performance: Analyze "underlying" operating income (excluding litigation and restructuring charges), which management states increased 7.4% for the six-month period.
• Currency Hedging: Review the effectiveness of hedging strategies given the significant negative impact of the strong U.S. dollar on international results.
• Y2K Contingency: Assess the progress of the Y2K remediation program and the potential for supply chain disruptions from third-party vendors.